Novo Nordisk India has cut prices of its blockbuster weight-loss and diabetes medications, as an onset of cheaper generic drugs raises competition for the Danish drugmaker in the world’s third most overweight country.
Novo Nordisk India Cuts Prices of Weight Loss, Diabetes Drugs
